Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044895791> ?p ?o ?g. }
- W2044895791 endingPage "851" @default.
- W2044895791 startingPage "842" @default.
- W2044895791 abstract "Methylglyoxal (MG) is a toxic-glucose metabolite and a major precursor of advanced glycation endproducts (AGEs). MG has been reported to result in inflammation by activating receptor for AGEs (RAGE). We recently found that Monascus-fermented metabolite monascin acts as a novel natural peroxisome proliferator-activated receptor-γ (PPARγ) agonist that improves insulin sensitivity. We investigated the metabolic, biochemical, and molecular abnormalities characteristic of type 2 diabetes in MG-treated Wistar rats treated with oral administration of monascin or rosiglitazone. Monascin (a novel PPARγ agonist) activated nuclear factor-erythroid 2-related factor 2 (Nrf2) and down-regulated hyperinsulinmia in oral glucose tolerance test (OGTT). Monascin was able to elevate glyoxalase-1 expression via activation of hepatic Nrf2, hence, resulting in MG metabolism to d-lactic acid and protected from AGEs production in MG-treated rats. Rosiglitazone did not activate Nrf2 nor glyoxalase expression to lower serum and hepatic AGEs levels. Monascin acts as a novel natural Nrf2 activator with PPARγ-agonist activity were confirmed by Nrf2 and PPARγ reporter assays in Hep G2 cells. These findings suggest that monascin acts as an anti-diabetic and anti-oxidative stress agent to a greater degree than rosiglitazone and thus may have therapeutic potential for the prevention of diabetes." @default.
- W2044895791 created "2016-06-24" @default.
- W2044895791 creator A5025628943 @default.
- W2044895791 creator A5028780184 @default.
- W2044895791 creator A5063899896 @default.
- W2044895791 creator A5064377880 @default.
- W2044895791 creator A5064577387 @default.
- W2044895791 date "2013-11-01" @default.
- W2044895791 modified "2023-10-16" @default.
- W2044895791 title "A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia" @default.
- W2044895791 cites W1494611500 @default.
- W2044895791 cites W1526037649 @default.
- W2044895791 cites W1570936570 @default.
- W2044895791 cites W1739321847 @default.
- W2044895791 cites W1824737122 @default.
- W2044895791 cites W1913619429 @default.
- W2044895791 cites W1971395059 @default.
- W2044895791 cites W1973924126 @default.
- W2044895791 cites W1980685359 @default.
- W2044895791 cites W1982377058 @default.
- W2044895791 cites W1984799928 @default.
- W2044895791 cites W1987857240 @default.
- W2044895791 cites W1994994450 @default.
- W2044895791 cites W1999113566 @default.
- W2044895791 cites W2001697674 @default.
- W2044895791 cites W2002065167 @default.
- W2044895791 cites W2003100591 @default.
- W2044895791 cites W2004197341 @default.
- W2044895791 cites W2006441826 @default.
- W2044895791 cites W2006867491 @default.
- W2044895791 cites W2007473325 @default.
- W2044895791 cites W2008201503 @default.
- W2044895791 cites W2009938323 @default.
- W2044895791 cites W2015930146 @default.
- W2044895791 cites W2016795949 @default.
- W2044895791 cites W2017390745 @default.
- W2044895791 cites W2018021558 @default.
- W2044895791 cites W2025093655 @default.
- W2044895791 cites W2029759541 @default.
- W2044895791 cites W2030900319 @default.
- W2044895791 cites W2038138751 @default.
- W2044895791 cites W2044521211 @default.
- W2044895791 cites W2044636787 @default.
- W2044895791 cites W2048246530 @default.
- W2044895791 cites W2049247238 @default.
- W2044895791 cites W2050051162 @default.
- W2044895791 cites W2050091252 @default.
- W2044895791 cites W2051309543 @default.
- W2044895791 cites W2062787370 @default.
- W2044895791 cites W2064116660 @default.
- W2044895791 cites W2067947009 @default.
- W2044895791 cites W2068135486 @default.
- W2044895791 cites W2073926725 @default.
- W2044895791 cites W2076668116 @default.
- W2044895791 cites W2082187899 @default.
- W2044895791 cites W2084536221 @default.
- W2044895791 cites W2094142721 @default.
- W2044895791 cites W2096261918 @default.
- W2044895791 cites W2096341618 @default.
- W2044895791 cites W2096657138 @default.
- W2044895791 cites W2100085143 @default.
- W2044895791 cites W2116655531 @default.
- W2044895791 cites W2120959748 @default.
- W2044895791 cites W2123603132 @default.
- W2044895791 cites W2130670794 @default.
- W2044895791 cites W2150695169 @default.
- W2044895791 cites W2153676881 @default.
- W2044895791 cites W2162514497 @default.
- W2044895791 cites W2164135579 @default.
- W2044895791 cites W2165667722 @default.
- W2044895791 cites W2171316300 @default.
- W2044895791 cites W2172012214 @default.
- W2044895791 cites W2229899302 @default.
- W2044895791 cites W2313252270 @default.
- W2044895791 cites W2333157744 @default.
- W2044895791 doi "https://doi.org/10.1016/j.taap.2013.07.004" @default.
- W2044895791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23954466" @default.
- W2044895791 hasPublicationYear "2013" @default.
- W2044895791 type Work @default.
- W2044895791 sameAs 2044895791 @default.
- W2044895791 citedByCount "52" @default.
- W2044895791 countsByYear W20448957912013 @default.
- W2044895791 countsByYear W20448957912014 @default.
- W2044895791 countsByYear W20448957912015 @default.
- W2044895791 countsByYear W20448957912016 @default.
- W2044895791 countsByYear W20448957912017 @default.
- W2044895791 countsByYear W20448957912018 @default.
- W2044895791 countsByYear W20448957912019 @default.
- W2044895791 countsByYear W20448957912020 @default.
- W2044895791 countsByYear W20448957912021 @default.
- W2044895791 countsByYear W20448957912022 @default.
- W2044895791 countsByYear W20448957912023 @default.
- W2044895791 crossrefType "journal-article" @default.
- W2044895791 hasAuthorship W2044895791A5025628943 @default.
- W2044895791 hasAuthorship W2044895791A5028780184 @default.
- W2044895791 hasAuthorship W2044895791A5063899896 @default.
- W2044895791 hasAuthorship W2044895791A5064377880 @default.
- W2044895791 hasAuthorship W2044895791A5064577387 @default.